Login|Register|Forget password|Dashboard Back to Home|Contact|Shopcart
Unverified1st Year

Taolight Pharma Co., Ltd.  

Search
新闻中心
  • 暂无新闻
产品分类
  • 暂无分类
联系方式
  • 联系人:Summer Niu
  • 电话:86-25-86112803
  • 传真:86-25-86112803
站内搜索
 
荣誉资质
  • 暂未上传
友情链接
  • 暂无链接
首页 > Products > Omeprazole Capsules Losec Mopral Gastrogard Moprial Omeprazolum Omeprazole
Omeprazole Capsules Losec Mopral Gastrogard Moprial Omeprazolum Omeprazole
单价 $1.00 / Pieces对比
询价 暂无
浏览 172
发货 Chinajiangsunanjing
过期 长期有效
更新 2020-05-16 04:43
 
详细信息
Product Name: Omeprazole Capsules Losec Mopral Gastrogard Moprial Omeprazolum Omeprazole Model NO.: 20mg Pharmaceutical Technology: Chemical Synthesis Type: Organic Chemicals Shape: Capsules State: Solid Suitable for: Elderly, Children, Adult Usage Mode: For oral administration Application: Internal Medicine Delivery Deadline: 35days Export: for Export Use only Trademark: TAOLIGHT PHARMA Transport Package: Carton Specification: 20mg Origin: China HS Code: 2941500000 Product Description Drug nameOmeprazole capsulesCAS119141-89-8Molecular formulaC17H19N3O3SMolecular weight345.41600Usage:Orally with water.Dosage:As directed by the physician.Shelf life:36 monthsStorage:Keep in acool, dry place and protect from light.Keep out of reach of children.PharmacologyAs a proton pump inhibitor, it is a fat-soluble weakly basic drug. It is concentrated in an acidic environment and acts specifically on the secretory microtubules formed by the apical membrane of the gastric mucosal wall and the tubular vesicles in the cytoplasm, that is, the site of the proton pump (H+, K+-ATPase) of the gastric wall. And converted into the active form of sulfenamide, irreversible binding to the sulfhydryl group of the proton pump through the disulfide bond, thereby inhibiting the activity of H+, K+-ATPase, blocking the final step of gastric acid secretion, and causing H+ in the parietal cells Can not be transported into the stomach cavity, so that the acid content in the gastric juice is greatly reduced. It has a strong inhibitory effect on gastric acid secretion caused by basal stomach acid and stimulation. It has obvious inhibitory effects on histamine, pentagastrin and vagus nerve-induced gastric acid secretion, and has strong and lasting inhibitory effect on gastric acid secretion caused by dibutyl cyclic adenosine monophosphate which cannot be inhibited by H2 receptor antagonist. After the drug was administered, the amount of gastric acid secretion decreased significantly, and the pH in the stomach increased rapidly. It relieves heartburn and pain faster. The cure rate for duodenal ulcer is also higher, and the recurrence rate is lower.Indication1. For gastric ulcer and duodenal ulcer. The two- and three-way regimen of omeprazole combined with antibiotics can be used to treat Helicobacter pylori (HP)-associated peptic ulcers.2. For reflux esophagitis, gastrinoma (Zhuo-Ai syndrome).3. Omeprazole intravenous injection can be used for the treatment of acute peptic ulcer bleeding, such as acute gastric mucosal bleeding.Adverse reactions1. Can have dry mouth, mild nausea, vomiting, bloating, constipation, diarrhea, abdominal pain, etc.; alanine aminotransferase (ALT), aspartate aminotransferase (AST) and elevated bilirubin also occur Usually mild and short-lived, most do not affect treatment. In addition, foreign data reported that the performance of atrophic gastritis can be observed in the gastric biopsy specimens of patients who have been treated with omeprazole for a long time.2. Neuropsychiatric system: may have paresthesia, dizziness, headache, lethargy, insomnia, peripheral neuritis and the like.3. metabolism/endocrine system: Long-term application of omeprazole can lead to vitamin B12 deficiency.4. Carcinogenicity: Animal experiments show that omeprazole can cause proliferation of the main endocrine cell-intestinal chromaffin cells in the bottom of the stomach and the stomach, and long-term medication can also cause gastric carcinoid.5. Others: may have rash, male mammary gland development, hemolytic anemia.For Export use only